Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	157.02	121.47	77.34	135.86	29.37
Cash & Short-Term Investments	157.02	121.47	77.34	135.86	29.37
Cash Growth	342.95%	57.06%	-43.08%	362.53%	-
Prepaid Expenses	2.44	2.83	2.34	0.13	-
Other Current Assets	-	0	0.37	0.7	0.03
Total Current Assets	159.46	124.29	80.05	136.68	29.41
Property, Plant & Equipment	11.16	12.26	13.78	0.17	-
Other Long-Term Assets	3.25	3.25	3.25	0	0
Total Assets	173.87	139.81	97.08	136.86	29.41
Accounts Payable	8.44	3.79	2.68	3.06	0.04
Accrued Expenses	15.14	10.51	8.09	3.78	0.25
Current Portion of Leases	2.68	2.61	2.83	-	-
Current Income Taxes Payable	-	0.16	0.51	0.53	0.04
Current Unearned Revenue	-	-	-	0.05	0.14
Other Current Liabilities	0.55	0.17	0.24	0.03	0.22
Total Current Liabilities	26.82	17.24	14.35	7.45	0.7
Long-Term Leases	7.72	9.03	10.65	-	-
Other Long-Term Liabilities	-	-	-	-	3.01
Total Liabilities	34.54	26.27	25	7.45	3.71
Common Stock	0	0	-	0	0
Additional Paid-In Capital	393.59	295.37	2.49	0.57	0.01
Retained Earnings	-254.25	-181.84	-115.45	-56.17	-5.55
Total Common Equity	139.33	113.54	-112.95	-55.6	-5.54
Shareholders' Equity	139.33	113.54	72.08	129.41	25.7
Total Liabilities & Equity	173.87	139.81	97.08	136.86	29.41
Total Debt	10.4	11.64	13.48	-	-
Net Cash (Debt)	146.62	109.83	63.85	135.86	29.37
Net Cash Growth	662.00%	72.00%	-53.00%	362.53%	-
Net Cash Per Share	5.30	20.51	39.17	87.50	20.38
Filing Date Shares Outstanding	33.07	26.65	1.61	1.58	1.51
Total Common Shares Outstanding	33.06	26.65	1.61	1.58	1.51
Working Capital	132.64	107.06	65.7	129.24	28.71
Book Value Per Share	4.21	4.26	-70.28	-35.18	-3.66
Tangible Book Value	139.33	113.54	-112.95	-55.6	-5.54
Tangible Book Value Per Share	4.21	4.26	-70.28	-35.18	-3.66
Machinery	1.21	0.89	0.65	0.19	-
Leasehold Improvements	0.27	0.25	0.23	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.